STOCK TITAN

Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results

(Moderate)
(Neutral)
Tags

Ridgetech (Nasdaq: RDGT) reported fiscal year 2026 revenue of $132.2 million for the year ended March 31, 2026, up 10.2% from $120.0 million, driven mainly by a full-year contribution from Allright’s online platform. Gross profit rose 23.8% to $4.75 million, lifting gross margin to 3.6% from 3.2%.

Offline wholesale revenue declined 0.8% to $117.9 million, while online platform revenue increased 1,190.8% to $14.3 million. Selling expenses nearly doubled and general and administrative costs increased, contributing to a loss from operations of $1.87 million. Net loss was $1.25 million (loss of $17.21 per share) versus prior-year net income of $10.2 million, which included an 11.65 million net gain from discontinued operations. Cash and cash equivalents increased to $17.9 million, total liabilities fell to $28.3 million, and shareholders’ equity rose to $40.8 million.

Loading...
Loading translation...

Positive

  • Revenue +10.2% YoY to $132.16 million in fiscal 2026
  • Online platform revenue up 1,190.8% to $14.29 million
  • Gross profit increased 23.8% to $4.75 million; margin improved to 3.6%
  • Cash and cash equivalents increased to $17.91 million from $12.78 million
  • Total liabilities decreased to $28.25 million from $34.85 million
  • Shareholders’ equity rose to $40.78 million from $29.64 million

Negative

  • Net result swung to $1.25 million loss from $10.20 million income
  • Operating loss widened to $1.87 million from $1.04 million
  • Operating cash flow moved to $1.39 million use from $1.25 million provision
  • Selling expenses rose 98.2% to $3.04 million
  • Offline wholesale revenue declined 0.8% to $117.87 million
  • Online platform gross margin fell to 5.6% from 7.4%

News Explained

The release adds an April 7, 2026 reverse split and reports $1.39 million of fiscal 2026 operating cash use.

Ridgetech has reported fiscal-year 2026 results for the year ended March 31, 2026; the release also records a 1-for-150 reverse share split effective April 7, 2026, with $887,271 ordinary shares issued and outstanding at year-end.

The company states that all share and per-share amounts were retroactively adjusted for the split, so the reported 887,271 shares are shown on a split-adjusted basis rather than as an unadjusted historical count.

For fiscal 2026, Ridgetech used $1.39 million in operating cash, while cash and cash equivalents stood at $17.91 million on March 31, 2026; the release also reports a $1.25 million net loss.

Key Figures

Revenue: $132.16 million Gross Profit: $4.75 million Gross Margin: 3.6% +5 more
8 metrics
Revenue $132.16 million Fiscal year ended March 31, 2026; up 10.2% year over year
Gross Profit $4.75 million Fiscal year ended March 31, 2026; up 23.8% year over year
Gross Margin 3.6% Fiscal year ended March 31, 2026; up from 3.2%
Net Loss $1.25 million Fiscal year ended March 31, 2026; compared with $10.20 million net income
Loss Per Share $17.21 per basic and diluted share Fiscal year ended March 31, 2026
Online Platform Revenue $14.29 million Fiscal year ended March 31, 2026; up 1,190.8% year over year
Cash and Cash Equivalents $17.91 million As of March 31, 2026; compared with $12.78 million
Operating Cash Flow $1.39 million used Fiscal year ended March 31, 2026; compared with $1.25 million provided

Key Terms

gross margin, operating margin, accounts receivable, reverse share split
4 terms
gross margin financial
"Gross margin was 3.6% for the fiscal year ended March 31, 2026"
Gross margin is the difference between how much money a company makes from selling its products and how much it costs to produce them, expressed as a percentage of sales. It shows how efficiently a company is turning sales into profit before other expenses like marketing or salaries. Higher gross margin means the company keeps more money from each sale, which is a good sign of financial health.
View in glossary
operating margin financial
"Operating margin was (1.4)% and (0.9)% for the fiscal years"
Operating margin shows how much profit a company makes from its core business activities after paying for costs like wages and materials. It’s useful because it tells you how efficiently a company is running—higher margins mean it keeps more money from each dollar of sales, which can indicate better management or stronger products.
View in glossary
accounts receivable financial
"an increase of approximately $3.46 million in accounts receivable"
Money a company is owed by its customers for goods or services already delivered but not yet paid for. Think of it like a stack of IOUs or open tabs: it represents future cash the business expects to collect. Investors watch accounts receivable because large or growing balances can signal strong sales or potential cash shortfalls if customers don’t pay, affecting liquidity, working capital and the company’s financial health.
reverse share split financial
"reflect the 1-for-150 reverse share split effective April 7, 2026"
A reverse share split is when a company reduces the number of its shares outstanding by combining multiple shares into one, effectively increasing the price of each share. For investors, this can help improve the company's image or meet stock exchange listing requirements, but it does not change the total value of their investment. It’s similar to turning many small pieces of a puzzle into fewer larger pieces—nothing new is added or lost, just rearranged.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

HANGZHOU, China, July 31, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2026.

Mr. Frank Zhao, Interim Chief Executive Officer and Chief Financial Officer of Ridgetech, commented, "Fiscal year 2026 marked a transformative year for Ridgetech as we completed our strategic transition to a wholesale-focused business model. Through the acquisition of Allright (Hangzhou) Internet Technology Co. Ltd ("Allright") and the divestiture of our retail drugstore business, we have strengthened our position as an online and offline wholesale distributor of pharmaceutical and healthcare products, establishing a more scalable and efficient operating platform.

"Our revenue increased 10.2% year over year to $132.2 million, driven primarily by the first full year contribution from Allright's online platform business. We also delivered a 23.8% increase in gross profit and improved our overall gross margin to 3.6%, reflecting the benefits of our optimized business mix and continued operational execution.

"Today, our business combines a strong offline wholesale network serving local customers with expanding nationwide online distribution through both our proprietary platform and leading third-party e-commerce platforms. We believe this integrated online and offline model enhances our market reach, broadens our customer base, and positions us to capture long-term opportunities in China's pharmaceutical distribution market.

"Looking ahead, we remain focused on executing our dual-engine growth strategy by expanding our digital distribution capabilities, strengthening our pharmaceutical ecosystem, and pursuing strategic initiatives that enhance operational efficiency and create long-term value for our shareholders."

Fiscal Year 2026 Financial Summary

  • Revenue was $132.16 million for the fiscal year ended March 31, 2026, an increase of 10.2% from $119.97 million for the same period of last year.
  • Gross profit was $4.75 million for the fiscal year ended March 31, 2026, an increase of 23.8% from $3.84 million for the same period of last year.
  • Gross margin was 3.6% for the fiscal year ended March 31, 2026, an increase from 3.2% for the same period of last year.
  • Net loss was $1.25 million, or $17.21 per basic and diluted loss per share, for the fiscal year ended March 31, 2026, compared to net income of $10.20 million, or $275.87 per basic and diluted earnings per share, for the same period of last year.

Fiscal Year 2026 Financial Results

Revenue

Revenue increased by $12.19 million, or 10.2%, to $132.16 million for the fiscal year ended March 31, 2026, from $119.97 million for the same period of last year.

Revenue from offline wholesale decreased by $0.99 million, or 0.8%, to $117.87 million for the fiscal year ended March 31, 2026, from $118.86 million for the same period of last year. The Company previously provided credit terms to certain offline customers. However, the Company experienced delayed repayments from several customers. Despite eventual recovery of the outstanding amounts, the Company decided to discontinue some of its credit sales effective March 2025 as a risk mitigation measure. As a result, the offline wholesale revenue declined.

Revenue from online platform increased by $13.18 million, or 1,190.8%, to $14.29 million for the fiscal year ended March 31, 2026, from $1.11 million for the same period of last year. This increase is primarily attributable to the inclusion of a full twelve months of Allright's online platform revenue in the year ended March 31, 2026, compared to only one month (March 2025) of such revenue in the prior year period. On February 28, 2025, the Company acquired Ridgeline International Limited ("Ridgeline") and its subsidiary, Allright, which is a rapidly growing online and offline wholesale distributor of pharmaceutical and other healthcare products such as health foods, cosmetics and daily necessities in China. Allright actively trades on popular online distribution platforms nationwide. Through these online platforms, the Company sells various medical products to retail pharmacies, clinics and other vendors across the country. Allright also has its own online distribution platform.

Gross profit and gross margin

Total cost of goods sold increased to $127.41 million for the fiscal year ended March 31, 2026, from $116.13 million for the same period of last year. Gross profit increased by $0.92 million, or 23.8%, to $4.75 million for the fiscal year ended March 31, 2026, from $3.84 million for the same period of last year. Overall gross margin increased by 0.4 percentage points to 3.6% for the fiscal year ended March 31, 2026, from 3.2% for the same period of last year.

Gross margins for offline wholesale and online platform were 3.4% and 5.6%, respectively, for the fiscal year ended March 31, 2026, compared to gross margins for offline wholesale and online platform of 3.2% and 7.4%, respectively, for the same period of last year.

Loss from operations

Sales and marketing expenses increased by $1.51 million, or 98.2%, to $3.04 million for the fiscal year ended March 31, 2026, from $1.53 million for the same period of last year. The increase was primarily attributable to the increase in drug distribution service fee resulting from the acquisition of Allright, which was recognized over 12 months this year, compared to just one month as the acquisition took place at the end of the fiscal year 2025. Overall, such expenses as a percentage of the Company's revenue were 2.3% and 1.3%, respectively, for the years ended March 31, 2026 and 2025.

General and administrative expenses increased by $0.24 million, or 7.2%, to $3.58 million for the fiscal year ended March 31, 2026, from $3.34 million for the same period of last year. The increase was primarily due to the increase in employee salary of approximately $0.31 million, offset by the decrease in exchange loss. Such expenses as a percentage of revenue decreased for the year ended March 31, 2026 to 2.7% from 2.8% for the same period a year ago. This increase in employee salary was primarily attributable to the acquisition of Ridgeline and its subsidiary Allright on February 28, 2025, which led to a rise in employee headcount and consequently an increase in employee salaries.

Loss from operations was $1.87 million for the fiscal year ended March 31, 2026, compared to $1.04 million for the same period of last year. Operating margin was (1.4)% and (0.9)% for the fiscal year ended March 31, 2026 and 2025, respectively.

Net loss from continuing operations

Net loss from continuing operations was $1.25 million and $1.45 million in the years ended March 31, 2026 and 2025.

Net income (loss)

Net loss was $1.25 million, or $17.21 per basic and diluted loss per share for the fiscal year ended March 31, 2026, compared to net income of $10.20 million, or $275.87 per basic and diluted earnings per share for the same period of last year.

Financial Condition

As of March 31, 2026, the Company had cash and cash equivalents of $17.91 million, compared to $12.78 million as of March 31, 2025. Net cash used in operating activities was $1.39 million for the fiscal year ended March 31, 2026, compared to net cash provided by operating activities of $1.25 million for the same period of last year. The change was primarily attributable to net loss of approximately $1.25 million, adjusted for non-cash item of depreciation and amortization expenses of approximately $0.36 million and changes in operating assets and liabilities including: (i) an increase of approximately $3.46 million in accounts receivable, (ii) an increase of approximately $2.04 million in other receivable, (iii) an increase of approximately $2.01 million in accounts payable, and (ⅳ) a decrease of approximately $1.95 million in inventories.

Net cash used in investing activities was $449 for the fiscal year ended March 31, 2026, compared to $18.14 million for the same period of last year. The change was primarily attributable to $449 used for purchases of long-term assets.

Net cash used in financing activities was $0.03 million for the fiscal year ended March 31, 2026, compared to net cash provided by financing activities of $1.51 million for the same period of last year. The change was primarily due to approximately $24.94 million in repayment of notes payable offset by approximately $10.88 million proceeds from equity and debt financing and approximately $14.35 million in proceeds from notes payable.

About Ridgetech, Inc.

Ridgetech, Inc. ("Ridgetech" or the "Company") is a growing online and offline wholesale distributor of pharmaceutical and other healthcare products in China. Ridgetech actively trades on popular online distribution platforms nationwide and has its own online distribution platform. The Company believes that trading on these platforms offers greater opportunities to distribute pharmaceutical products nationwide. For more information about the Company, please visit www.ridgetch.com. The Company routinely posts important information on its website.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. These forward-looking statements include, but are not limited to, statements concerning the Company's strategic transformation, integration of acquired businesses, development of its online and offline pharmaceutical distribution capabilities and ecosystem, and its ability to generate long-term growth and shareholder value. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to," or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct. Factors that could cause actual results or events to differ materially from those reflected in the Company's forward-looking statements including risks related to the Company's ability to satisfy applicable procurement conditions, changes in market demand, the Company's ability to successfully implement and promote its digital platform, and those other risks described in the Company's most recent registration statement, most recent annual report on Form 20-F and in its other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

Company Contact: 

Frank Zhao
Interim Chief Executive Officer and Chief Financial Officer
+86-571-88077108
frank.zhao@ridgetch.com

Investor Relations Contact:

Tina Xiao
Ascent Investor Relations LLC
+1-646-932-7242
investors@ascent-ir.com

 

RIDGETECH, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS




March 31,



March 31,




2026



2025


ASSETS







CURRENT ASSETS







Cash and cash equivalents


$

17,905,262



$

12,779,781


Restricted cash



8,519




5,761,294


Trade accounts receivables



32,466,688




27,811,813


Inventories



8,259,002




9,758,071


Other receivables, net



5,196,109




2,419,671


Advances to suppliers



98,359




433,140


Due from related parties



329,258




-


Other current assets



292,995




745,477


Total current assets



64,556,192




59,709,247











NON-CURRENT ASSETS









Property and equipment, net



5,723




8,931


Intangible assets, net



3,002,053




3,302,961


Goodwill



1,463,733




1,463,733


Total non-current assets



4,471,509




4,775,625


Total assets


$

69,027,701



$

64,484,872











LIABILITIES AND SHAREHOLDERS' EQUITY









CURRENT LIABILITIES









Accounts payable


$

22,757,939



$

19,666,664


Notes payable



22,669




10,386,612


Other payables



2,752,548




2,319,139


Due to related parties



-




2,130


Customer deposits



364,150




264,068


Taxes payable



1,790,902




1,521,546


Accrued liabilities



206,502




196,210


Total current liabilities



27,894,710




34,356,369











NON-CURRENT LIABILITIES









Deferred tax liabilities



356,353




492,121


Total non-current liabilities



356,353




492,121


Total liabilities



28,251,063




34,848,490











COMMITMENTS AND CONTINGENCIES









SHAREHOLDERS' EQUITY









Ordinary shares; $0.15 par value; 240,000,000 shares authorized;
     887,271 and 39,033 shares issued and outstanding as of March 31,
     2026 and 2025, respectively*



133,091




5,855


Preferred shares; $0.001 par value; 10,000,000 shares authorized; nil
     issued and outstanding as of March 31, 2026 and 2025



-




-


Additional paid-in capital



103,898,531




93,142,510


Statutory reserves



-




-


Accumulated deficit



(64,563,201)




(63,312,779)


Accumulated other comprehensive income



1,308,217




(199,204)


Total shareholders' equity



40,776,638




29,636,382


Total liabilities and shareholders' equity


$

69,027,701



$

64,484,872



* All share numbers and share amounts presented have been retroactively adjusted to reflect the 1-for-150 
reverse share split effective April 7, 2026.

 

RIDGETECH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)




For the years ended
March 31,




2026



2025



2024


REVENUES, NET


$

132,163,734



$

119,971,638



$

123,994,053















COST OF GOODS SOLD



127,409,588




116,132,823




119,115,636















GROSS PROFIT



4,754,146




3,838,815




4,878,417















SELLING EXPENSES



3,040,136




1,534,200




934,223


GENERAL AND ADMINISTRATIVE EXPENSES



3,580,025




3,339,954




3,348,112


TOTAL OPERATING EXPENSES



6,620,161




4,874,154




4,282,335















INCOME (LOSS) FROM OPERATIONS



(1,866,015)




(1,035,339)




596,082















OTHER INCOME (EXPENSES):













INTEREST INCOME



455,061




92,834




197,763


INTEREST EXPENSES



(67,069)




-




-


INVESTMENT INCOME (EXPENSES)



229,657




-




(1,607,537)


OTHER INCOME (EXPENSES)



(101,154)




(8,155)




(13,377)


TOTAL OF OTHER INCOME (EXPENSES)



516,495




84,679




(1,423,151)















LOSS BEFORE INCOME TAXES



(1,349,520)




(950,660)




(827,069)















(BENEFIT) PROVISION FOR INCOME TAXES



(99,098)




503,524




(41,363)


NET LOSS FROM CONTINUING OPERATIONS



(1,250,422)




(1,454,184)




(785,706)


NET LOSS FROM DISCONTINUED OPERATIONS, NET
     OF TAXES



-




(4,103,718)




(3,448,536)


GAIN OF DIVESTITURE JIUXIN INVESTMENT



-




15,757,753




-


NET GAIN(LOSS) FROM DISCONTINUED
     OPERATIONS, NET OF TAX



-




11,654,035




(3,448,536)















NET (LOSS) INCOME



(1,250,422)




10,199,851




(4,234,242)















LESS: NET LOSS ATTRIBUTABLE TO

     NONCONTROLLING INTEREST



-




5,384




(14)















NET (LOSS) INCOME ATTRIBUTABLE TO
     RIDGETECH, INC.



(1,250,422)




10,194,467




(4,234,228)


NET (LOSS) INCOME ATTRIBUTABLE TO
     RIDGETECH, INC. FROM CONTINUING
     OPERATIONS



(1,250,422)




(1,454,184)




(785,706)


NET (LOSS) INCOME ATTRIBUTABLE TO
     RIDGETECH, INC. FROM DISCONTINUED
     OPERATIONS



-




11,648,651




(3,448,522)















OTHER COMPREHENSIVE INCOME (LOSS)













FOREIGN CURRENCY TRANSLATION ADJUSTMENTS



1,507,421




(1,204,966)




(729,373)


COMPREHENSIVE INCOME (LOSS)



256,999




8,994,885




(4,963,615)















WEIGHTED AVERAGE NUMBER OF SHARES*:













Basic



72,668




36,954




9,628


Diluted



72,668




36,954




9,628















(LOSS) INCOME PER SHARE*:













Basic


$

(17.21)



$

275.87



$

(439.78)


Diluted


$

(17.21)



$

275.87



$

(439.78)



*All share and per-share amounts presented have been retroactively adjusted to reflect the 1-for-150 reverse 
share split effective April 7, 2026.

 

RIDGETECH, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS




For the years ended
March 31,




2026



2025



2024


CASH FLOWS FROM OPERATING ACTIVITIES:










Net (loss) income


$

(1,250,422)



$

10,199,851



$

(4,234,242)


Adjustments to reconcile net (loss) income to net cash used in
     operating activities:













     Depreciation and amortization



363,686




1,137,240




790,449


Provision for (reversal of) doubtful accounts



(428,420)




85,642




(249,257)


Amortization of right-of-use assets



-




4,879,012




4,594,172


Loss from disposal of property and equipment



-




-




107,251


Gain of divestiture Jiuxin Investment



-




(15,757,753)




-


Deferred tax expenses(benefits)



(79,692)




(29,822)




-


Investment loss



-




-




1,607,537


Change in operating assets and liabilities:













Accounts receivable



(3,461,596)




10,040,414




(1,804,440)


Notes receivable



29,743




(29,271)




19,943


Inventories and biological assets



1,948,887




405,822




(1,699,621)


Other receivables



(2,042,206)




(11,758,658)




(672,830)


Advances to suppliers



449,647




(341,702)




(839,221)


Long term deposit



-




(1,361,613)




(132,568)


Other current assets



477,144




-




19,076


Other noncurrent assets



-




(359,114)




69,539


Amount due from related parties



-




-




(317,828)


Accounts payable



2,009,206




(21,128,762)




6,002,186


Other payables and accrued liabilities



321,435




28,752,570




868,975


Customer deposits



83,870




(162,940)




(144,761)


Taxes payable



184,773




1,314,644




(948,277)


Operating lease liabilities



-




(4,637,790)




(6,191,522)


Net cash provided by (used in) operating activities



(1,393,945)




1,247,770




(3,155,439)















CASH FLOWS FROM INVESTING ACTIVITIES:













Acquisition of equipment and building



(449)




(155,360)




(330,677)


Investment in a joint venture



-




-




(1,116,212)


Purchases of intangible assets



-




-




(66,973)


Additions to leasehold improvements



-




(459,907)




(525,988)


Acquisition of Ridgeline, net of cash acquired



-




4,833,439




-


Divestiture Jiuxin Investment, net of cash disposed



-




(22,353,250)




-


Net cash used in investing activities



(449)




(18,135,078)




(2,039,850)















CASH FLOWS FROM FINANCING ACTIVITIES:













Proceeds from short-term bank loan



-




-




1,116,212


Repayment of short-term bank loan



-




(277,266)




(837,159)


Proceeds from notes payable



14,353,624




51,689,531




56,875,403


Repayment of notes payable



(24,944,614)




(56,365,693)




(52,997,171)


Net proceeds from issuance of shares and warrants in private
     placements



10,883,257




7,633,000




2,589,600


Proceeds from other payable-related parties



-




325,784




1,257,406


Repayment of other payable-related parties



(321,981)




(1,499,764)




-


Net cash provided by (used in) financing activities



(29,714)




1,505,592




8,004,291















EFFECT OF EXCHANGE RATE ON CASH



796,814




1,048,620




(1,505,475)















(DECREASE) INCREASE I IN CASH AND CASH
     EQUIVALENTS AND RESTRICTED CASH



(627,294)




(14,333,096)




1,303,527


CASH AND CASH EQUIVALENTS AND RESTRICTED
     CASH, beginning of year



18,541,075




32,874,171




31,570,644


CASH AND CASH EQUIVALENTS AND RESTRICTED
     CASH, end of year


$

17,913,781



$

18,541,075



$

32,874,171















SUPPLEMENTAL DISCLOSURE OF CASH FLOW
     INFORMATION:













Cash paid for income taxes


$

55,348



$

137,456



$

149,023


Cash paid for interest



67,069




6,289




13,604















NON-CASH ACTIVITIES:













Cashless exercise of warrants


$

51,671



$

-



$

-


Issuance of shares for acquisition of subsidiaries



-




3,582,250




-


Cancellation of shares for disposal of subsidiaries



-




4,102,848




-


Subscription receivable from issuance of ordinary shares



3,791,077




-




-



(a) The cash flows related to discontinued operations have not been segregated. Accordingly, the

Consolidated Statements of Cash Flows include the results of continuing and discontinued operations

 

 

Cision View original content:https://www.prnewswire.com/news-releases/ridgetech-inc-reports-fiscal-year-2026-financial-results-302839643.html

SOURCE Ridgetech, Inc.

FAQ

How did Ridgetech (Nasdaq: RDGT) perform financially in fiscal year 2026?

Ridgetech reported fiscal 2026 revenue of $132.16 million, up 10.2% year over year. According to Ridgetech, gross profit rose 23.8% to $4.75 million, but the company posted a net loss of $1.25 million, compared with prior-year net income of $10.20 million.

Why did Ridgetech report a net loss in fiscal 2026 after a profit in 2025?

Ridgetech recorded a net loss of $1.25 million in fiscal 2026 versus $10.20 million net income in 2025. According to Ridgetech, the prior year included an $11.65 million net gain from discontinued operations, including the Jiuxin Investment divestiture, which did not recur in 2026.

How did Ridgetech’s online platform business grow in fiscal 2026 (RDGT)?

Ridgetech’s online platform revenue grew to $14.29 million in fiscal 2026, a 1,190.8% year-over-year increase. According to Ridgetech, this jump reflects a full twelve months of Allright’s online revenue in 2026, compared with only one month of contribution in fiscal 2025.

What is Ridgetech’s cash and debt position as of March 31, 2026?

As of March 31, 2026, Ridgetech held $17.91 million in cash and cash equivalents, up from $12.78 million. According to Ridgetech, notes payable decreased sharply to $22,669 from $10.39 million, and total liabilities fell to $28.25 million from $34.85 million.

How did the Allright acquisition impact Ridgetech’s 2026 results (RDGT)?

Allright significantly boosted Ridgetech’s online revenue, which reached $14.29 million in fiscal 2026 versus $1.11 million in 2025. According to Ridgetech, the increase reflects a full year of Allright’s online platform operations, while also contributing to higher selling expenses through drug distribution service fees.

What happened to Ridgetech’s operating expenses and margins in fiscal 2026?

Ridgetech’s selling expenses rose to $3.04 million and general and administrative expenses to $3.58 million in fiscal 2026. According to Ridgetech, total operating expenses reached $6.62 million, leading to an operating loss of $1.87 million and an operating margin of negative 1.4%.